Zhang Huaisheng, Harmon Moeshia, Radoshitzky Sheli R, Soloveva Veronica, Kane Christopher D, Duplantier Allen J, Ogungbe Ifedayo Victor
Department of Chemistry, Physics, and Atmospheric Sciences, Jackson State University, Jackson, Mississippi 39217-0095, United States.
The Geneva Foundation, Countermeasure Development Division, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), Frederick, Maryland 21702-5011, United States.
ACS Med Chem Lett. 2020 Sep 2;11(11):2139-2145. doi: 10.1021/acsmedchemlett.0c00215. eCollection 2020 Nov 12.
Emerging infectious diseases like those caused by arboviruses such as Venezuelan equine encephalitis virus (VEEV) pose a serious threat to public health systems. Development of medical countermeasures against emerging infectious diseases are of utmost importance. In this work, an acrylate and vinyl sulfone-based chemical series was investigated as promising starting scaffolds against VEEV and as inhibitors of the cysteine protease domain of VEEV's nonstructural protein 2 (nsP2). Primary screen and dose response studies were performed to evaluate the potency and cytotoxicity of the compounds. The results provide structural insights into a new class of potent nonpeptidic covalent inhibitors of nsP2 cysteine protease represented by compound (VEEV TrD, EC = 2.4 μM (HeLa), 1.6 μM (Vero E6)). These results may facilitate the evolution of the compounds into selective and broad-spectrum anti-alphaviral drug leads.
像委内瑞拉马脑炎病毒(VEEV)等虫媒病毒引起的新发传染病对公共卫生系统构成严重威胁。开发针对新发传染病的医学对策至关重要。在这项工作中,研究了一种基于丙烯酸酯和乙烯基砜的化学系列,作为对抗VEEV的有前景的起始骨架以及VEEV非结构蛋白2(nsP2)的半胱氨酸蛋白酶结构域的抑制剂。进行了初步筛选和剂量反应研究以评估化合物的效力和细胞毒性。结果为以化合物(VEEV TrD,EC = 2.4 μM(HeLa),1.6 μM(Vero E6))为代表的一类新型有效的nsP2半胱氨酸蛋白酶非肽共价抑制剂提供了结构见解。这些结果可能有助于将这些化合物演变为选择性和广谱抗α病毒药物先导物。